Joint · GILEAD SCIENCES, INC. · Gilead Sciences, Inc. - Common Stock
Side
SELL
Value
$1,001 – $15K
Shares
—
Price
—
Executed
May 8, 2024
Disclosed
Aug 5, 2026
Disclosure timeline819 days from execution to publication
May 8 executedAug 5, 2026 disclosed
GILD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 819 days after execution (STOCK Act deadline: 45)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
Low: $1,001
High: $15,000
= $8,001
What this establishes
Tommy Tuberville reported a sale (full) of Gilead Sciences, Inc. - Common Stock (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
Extraction
Method
Structured mirror
Confidence
1.00
Joint
Tommy Tubervillebioguide:T000278
Issuer
GILEAD SCIENCES, INC.cik:0000882095
Revision history · 0
No field has changed since this record was first ingested.
